Oncology Clinical Trials in Kansas City, MO

As of August 2026, 89 paid clinical trials are recruiting for Oncology in Kansas City, Missouri. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

90 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Kansas City, MO.

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for Chronic Lymphocytic Leukemia

Drug: Venetoclax

Sites in Kansas City +3 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 80

Code: NCT06520098·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Barrett's Esophagus Related Neoplasia (BERN) Project

for Barrett's Esophagus

1 location in Kansas City

Sponsor: Midwest Biomedical Research

Sex: All·Age: 18+

Code: NCT00590239·Recruiting·Listed Jan 2008

Apply to this trial

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

for Barrett's Esophagus

1 location in Kansas City

Sponsor: Midwest Biomedical Research

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT00574327·Recruiting·Listed Dec 2007

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Kansas City, St Louis +83 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Sites in Kansas City, Lee's Summit +61 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT07441681·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in Kansas City, St Louis +70 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Kansas City, St Louis +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 99

Code: NCT06467357·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Kansas City, Bridgeton +63 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Kansas City +48 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Conditions in Oncology (Kansas City, MO)

Breast cancer· 20 Non-small cell lung cancer (NSCLC)· 15 Solid tumor· 11 Acute myeloid leukemia (AML)· 7 Metastatic breast cancer· 6 Chronic lymphocytic leukemia (CLL)· 6 Myelodysplastic syndromes (MDS)· 6 Hematologic malignancy· 6 Cancer (any)· 6 Lung cancer· 4 Colorectal cancer· 4 Ovarian cancer· 4 Leukemia (other)· 4 Non-Hodgkin lymphoma· 4 Melanoma· 4 Neuroblastoma· 4 Pancreatic cancer· 3 Esophageal cancer· 3 Gastroesophageal junction cancer· 3 Prostate cancer· 3 Endometrial cancer· 3 Multiple myeloma· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Small lymphocytic lymphoma· 3 Metastatic colorectal cancer· 2 Gastric cancer· 2 Liver cancer· 2 Biliary tract cancer· 2 Bladder cancer· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Sarcoma· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Rhabdomyosarcoma· 2 Neuroendocrine tumors· 2 HER2-positive breast cancer· 1 Colon cancer· 1 Rectal cancer· 1 Metastatic prostate cancer· 1 Kidney cancer· 1 Fallopian tube cancer· 1 Glioblastoma· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Skin cancer· 1 Head and neck cancer· 1 Thyroid cancer· 1 Pediatric cancer· 1 Mesothelioma· 1